FOMC Eve Calm, Tech and Semis Lead as Oil Breaks $100 Ahead of Fed Decision
- S&P 500 closed at 7,722.60 (+0.60%) and Nasdaq at 26,477.81 (+1.18%) as tech and semiconductor stocks extended their rally for a second day, led by AMD's $1B Meta investment announcement.
- Boeing plunged 10.69% to an 18-month low after Q3 earnings missed estimates and CEO Ortberg warned of extended 737 Max production delays, erasing roughly $10B in market value.
- Oil surged above $101/bbl (+1.71%) on tightening supply expectations, lifting energy ETFs and pushing XLE to a $204M inflow day despite the sector lagging on the prior session.
- The FOMC two-day meeting begins today with a rate decision expected Wednesday Oct 29; markets broadly anticipate a hold as the Fed weighs elevated inflation against midterm election proximity.
- Anthropic filed its S-1 for a Nasdaq listing under ticker ANT, adding to the AI IPO pipeline and reinforcing positive sentiment around the AI ecosystem.
- 01 FOMC two-day meeting begins today (Oct 28), decision due Oct 29, market pricing a hold as Fed Chair Warsh weighs elevated inflation data and midterm election proximity.
- 02 AMD announced a $1B strategic investment in Meta, with Meta able to earn up to 160M AMD shares by purchasing AMD AI chips, deepening the AI ecosystem partnership.
- 03 Boeing Q3 loss of $0.26/share missed estimates; CEO flagged extended 737 Max production delays, sending shares to an 18-month low and erasing ~$10B in market cap.
- 04 Crude oil broke above $101/bbl (+1.71%) on supply concerns, with WTI trading at $101.61, supporting energy sector flows.
- 05 Anthropic filed Form S-1 with the SEC for a planned Nasdaq listing under ticker ANT, adding to the AI IPO pipeline.
- 06 JLL reported Q3 adjusted EPS of $6.76 (+9.4% beat), raised full-year guidance, and announced a $500M accelerated share repurchase program.
- 07 ADP reported Q1 revenue of $5.49B (+6% YoY) and raised FY2027 guidance, though the stock closed -2.66% on the session.
- 08 Palvella Therapeutics announced FDA Priority Review for QTORIN rapamycin NDA with a PDUFA date of Feb 28, 2027.
- Russell 2000 at 2,818.87 (+1.16%) reclaimed its 200-day SMA (2,802.25) and 21-day SMA (2,788.57), suggesting broadening participation beyond mega-cap tech.
- Dow Jones at 52,377.57 (+0.03%) holds above its 50-day (52,270.97) and 200-day (50,562.16) SMAs with a bullish MACD crossover.
Names in focus based on expected market-moving catalysts and technical setups. Descriptive commentary only, not investment advice or a recommendation to buy or sell any security.
The session sets up for a cautiously positive open, with tech and semiconductor momentum carrying into a second day and oil above $100 supporting energy names. The FOMC meeting kickoff is the dominant event, markets broadly expect a hold, but any hawkish lean in the statement or dot-plot signals could trigger a reversal, particularly in rate-sensitive sectors. The VIX at 17.48 suggests complacency, leaving the tape vulnerable to a Fed surprise. Key levels to watch: S&P 500 resistance at 7,792 and support at 7,622; a break of either would set the tone for the rest of the week.
This report is for informational and educational purposes only. It is not investment advice, a research report within the meaning of applicable securities regulations, or a recommendation, solicitation, or offer to buy or sell any security.
References to expected price moves, support and resistance levels, or names "in focus" are descriptive observations about market conditions and expected behaviour, not directives to take a position. SecBot is not a registered investment adviser, broker-dealer, or financial planner. Past performance does not indicate future results. Any investment decisions are solely your own and you should consult a qualified financial professional who understands your individual circumstances before acting on any information herein.
SecBot and its affiliates may hold positions in securities mentioned. Figures are sourced from third-party data providers and may contain errors; readers should independently verify before relying on any specific number.